COMMUNIQUÉS West-GlobeNewswire

Axsome Therapeutics Announces Positive Outcome of Interim Analysis of ADVANCE-1 Phase 2/3 Trial of AXS-05 in Alzheimer’s Disease Agitation

10/12/2018 - 13:00

IDMC recommends continuation of trial evaluating AXS-05 versus placebo in Alzheimer’s disease agitation IDMC recommends no further enrollment to single-agent bupropion arm NEW YORK, Dec. 10, 2018 (GLOBE NEWSWIRE) -- [...]

Trevena Promotes Robert T. Yoder to Senior Vice President and Chief Business Officer

10/12/2018 - 13:00

CHESTERBROOK, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in [...]

Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis

10/12/2018 - 13:00

Company to Conduct Conference Call and Webcast Today at 8:00am ET / 5:00am PT REDWOOD CITY, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company [...]

Emerald Health Sees License Expansion of Pure Sunfarms Cannabis Production Operation to 687,000 Square Feet, one of Largest Production Capacities in Canada

10/12/2018 - 13:00

1.1 million square foot Pure Sunfarms facility steadily ramps capacity and production with industry-leading quality and yields in line with expectations VICTORIA, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- [...]

Axovant Reports Results of Exploratory Phase 2 Clinical Study of Nelotanserin in Lewy Body Dementia Patients Experiencing REM Sleep Behavior Disorder

10/12/2018 - 13:00

Primary efficacy endpoint assessed by sleep laboratory video assessment was not met Axovant is discontinuing clinical development of nelotanserin BASEL, Switzerland, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences ( [...]

Active Biotech provides updated information about the company's financial position

10/12/2018 - 12:31

PRESS RELEASE As announced in connection with the interim report for January-September 2018 Active Biotech has requested, from the bank that finances the company's property in Lund, that the agreed deadline for the [...]

LHC Group and LifePoint Health expand partnership with two acquisitions in North Carolina and Virginia

10/12/2018 - 12:30

LAFAYETTE, La., Dec. 10, 2018 (GLOBE NEWSWIRE) -- LHC Group (NASDAQ: LHCG) and LifePoint Health® today announced the continued expansion of their partnership. The companies have finalized two transactions to purchase [...]

Emblem launches new line of Oil Capsules

10/12/2018 - 12:30

Capsules are latest addition to the Company’s growing line of innovative medical cannabis products TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through [...]

BeiGene to Present Clinical Data on Anti-PD-1 Antibody Tislelizumab at the European Society for Medical Oncology Immuno-Oncology Congress

10/12/2018 - 12:05

CAMBRIDGE, Mass., and BEIJING, China, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Achillion Interim Clinical Trial Data and Strategic Update Planned for Dec 17th, 2018

10/12/2018 - 12:00

NEW HAVEN, Conn., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company focused on advancing its orally administered factor D complement inhibitors [...]

OraSure Technologies Announces 2019 Annual Meeting Date

10/12/2018 - 12:00

BETHLEHEM, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2019 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT (7:00 a.m. PDT) on [...]

Orphazyme expects to announce results of full data set for Niemann-Pick disease Type C (NPC) Phase II/III trial in Q1 2019

10/12/2018 - 10:38

Orphazyme A/S Company announcement No. 14/2018 Company Registration No. 32266355 Copenhagen, December 10, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with [...]

German Clinic Orders Second Acarix CADScor®System to Further Boost Patient Capacity

10/12/2018 - 10:01

Press release Malmö, Sweden 10 th of December 2018 German Clinic Orders Second Acarix CADScor ® System to Further Boost Patient Capacity After three months of strong results using Acarix's CADScor®System to evaluate [...]

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 5, 2018

10/12/2018 - 08:10

Disclosure of Share Capital and Voting Rights Outstanding as of December 5, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

EssilorLuxottica : Nombre total de droits de vote et d'actions composant le capital social au 5 décembre 2018

10/12/2018 - 08:10

Nombre total de droits de vote et d'actions composant le capital social au 5 décembre 2018 (Conformément à l'article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l'AMF) [...]

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2018

10/12/2018 - 08:07

Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité [...]

EssilorLuxottica : Nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2018

10/12/2018 - 08:07

Nombre total de droits de vote et d'actions composant le capital social au 30 novembre 2018 (Conformément à l'article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l'AMF) [...]

Mereo BioPharma to Present at The BMO Prescriptions for Success Healthcare Conference on 12 December 2018

10/12/2018 - 08:00

Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") LONDON, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (AIM: MPH), a clinical stage, UK-based, biopharmaceutical company focused on rare [...]

Bio-on and Hera create Lux-on the new challenge to produce bioplastic from CO2.

10/12/2018 - 07:59

Newco Lux-on created by Bio-on, alongside Gruppo Hera, to develop a revolutionary technology to produce biopolymers from CO2 (carbon dioxide). Following 2 years of research by Bio-on scientists working in Italy and USA [...]